• 1. Synthesis of the suicide substrate D-propargylglycine stereospecifically labelled with deuterium and investigation of its oxidation by D-amino acid oxidase?1
  Nicola J. Church,Douglas W. Young J. Chem. Soc. Perkin Trans. 1 1998 1475

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzopyrans 2,2-dimethyl-1-benzopyrans
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzopyrans 1-benzopyrans 2,2-dimethyl-1-benzopyrans

Introduction to 2,2,5,7,8-Pentamethylchroman-6-sulfonyl chloride (CAS No. 112160-39-1) and Its Applications in Modern Chemical Biology

2,2,5,7,8-Pentamethylchroman-6-sulfonyl chloride, identified by the Chemical Abstracts Service Number (CAS No.) 112160-39-1, is a highly specialized organic compound that has garnered significant attention in the field of chemical biology and pharmaceutical research. This compound belongs to the chromane family, characterized by a benzene ring fused with a cyclohexane ring. The presence of multiple methyl substituents and a sulfonyl chloride functional group at the 6-position imparts unique reactivity and makes it a valuable intermediate in synthetic chemistry and drug development.

The sulfonyl chloride moiety in this molecule is particularly noteworthy due to its strong electrophilic nature, which facilitates nucleophilic substitution reactions. This property is exploited in various synthetic pathways to introduce sulfonyl groups into more complex molecules, enabling the construction of bioactive scaffolds. The pentamethylchroman backbone provides stability and rigidity, making it an ideal candidate for designing molecules with specific spatial orientations required for biological interactions.

In recent years, there has been growing interest in 2,2,5,7,8-Pentamethylchroman-6-sulfonyl chloride for its potential applications in medicinal chemistry. Researchers have leveraged its structural features to develop novel compounds with therapeutic properties. For instance, derivatives of this compound have been explored as inhibitors of enzymes involved in inflammatory pathways. The sulfonyl group can be further functionalized to create potent pharmacophores that interact with biological targets with high selectivity.

One of the most compelling aspects of 2,2,5,7,8-Pentamethylchroman-6-sulfonyl chloride is its versatility in synthetic transformations. The sulfonyl chloride can be hydrolyzed to form sulfonic acids or reacted with amines to yield sulfonamides. These transformations are fundamental in constructing a wide range of biologically active molecules. Additionally, the chromane ring can undergo various modifications, such as oxidation or reduction, allowing for further diversification of the molecular structure.

Recent studies have highlighted the utility of 2,2,5,7,8-Pentamethylchroman-6-sulfonyl chloride in the development of photoactive compounds. The chromane core absorbs light in the visible spectrum and can be incorporated into materials designed for photodynamic therapy or as photosensitizers. The presence of electron-withdrawing groups like the sulfonyl chloride enhances the photophysical properties of these compounds, making them more effective in light-driven biological processes.

The pharmaceutical industry has also shown interest in this compound due to its potential as a building block for drug candidates. By modifying the sulfonyl group or the chromane ring, chemists can generate libraries of compounds for high-throughput screening. This approach has been instrumental in identifying novel therapeutics against various diseases. The structural motif present in 2,2,5,7,8-Pentamethylchroman-6-sulfonyl chloride is reminiscent of natural products known for their bioactivity.

In conclusion,2,2,5,7,8-Pentamethylchroman-6-sulfonyl chloride (CAS No. 112160-39-1) represents a fascinating compound with diverse applications in chemical biology and drug development. Its unique structural features and reactivity make it a valuable tool for synthetic chemists and medicinal chemists alike. As research continues to uncover new ways to exploit its potential,this compound is poised to play an increasingly important role in the discovery and development of innovative therapeutics.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)